Two-drug regimen of dolutegravir plus lamivudine (DTG+3TC) is noninferior to dolutegravir plus tenofovir/emtricitabine (DTG+TDF/FTC) at 48 weeks in antiretroviral treatment-naive adults with HIV-1 infection: subgroup analyses in the GEMINI studies.

Details

Language :

English

ISSN :

18760341

Volume :

12

Issue :

1

Database :

Supplemental Index

Journal :

Journal of Infection & Public Health

Publication Type :

Academic Journal

Accession number :

134017622

Full Text :

https://doi.org/10.1016/j.jiph.2018.10.127